TRAPHACO |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 81,000 VND | 0.00% |
|
-0.74% | -8.99% |
| Sales 2022 | 2,399B 93.56M 130M | Sales 2023 | 2,299B 89.67M 124M | Capitalization | 3,689B 144M 199M |
|---|---|---|---|---|---|
| Net income 2022 | 269B 10.5M 14.53M | Net income 2023 | 263B 10.27M 14.22M | EV / Sales 2022 | 1.35 x |
| Net cash position 2022 | 462B 18.01M 24.93M | Net cash position 2023 | 614B 23.96M 33.18M | EV / Sales 2023 | 1.34 x |
| P/E ratio 2022 |
15.6
x | P/E ratio 2023 |
16.1
x | Employees | 1,481 |
| Yield 2022 |
3.37% | Yield 2023 |
-
| Free-Float | 59.88% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 week | -0.74% | ||
| Current month | -0.61% | ||
| 1 month | +1.25% | ||
| 3 months | -1.22% | ||
| 6 months | -5.26% | ||
| Current year | -8.99% |
1 week
79 600.00
81 400.00
1 month
79 300.0083 900.00
Current year
78 600.0089 000.00
1 year
75 000.0093 400.00
3 years
69 000.00105 000.00
5 years
43 100.00105 000.00
10 years
41 964.29142 000.00
| Managers | Title | Age | Since |
|---|---|---|---|
Ma Tuc Tran
CEO | Chief Executive Officer | 59 | 93-12-31 |
Thuan Thi Vu
CHM | Chairman | 68 | 79-12-31 |
Thai Son Pham
SEC | Corporate Secretary | - | 18-03-29 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Thuan Thi Vu
CHM | Chairman | 68 | 79-12-31 |
Ma Tuc Tran
CEO | Chief Executive Officer | 59 | 93-12-31 |
Ruoc Thi Hoang
PRN | Corporate Officer/Principal | 62 | 83-04-30 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-21 | 81,000 | 0.00% | 1,200 |
| 24-06-20 | 81,000 | +1.25% | 1,600 |
| 24-06-19 | 80,000 | 0.00% | 200 |
| 24-06-18 | 80,000 | -0.37% | 1,900 |
| 24-06-17 | 80,300 | -1.59% | 4,100 |
End-of-day quote Ho Chi Minh S.E., June 20, 2024
More quotes
Traphaco Joint Stock Company is a Vietnam-based pharmaceutical manufacturer. The Company manufactures and trades pharmaceutical products, chemicals, functional food, cosmetic products and other medical equipment and supplies. It is also involved in the cultivation and processing of drug materials, medical technology transfer, as well as the provision of consulting services in the pharmaceutical industry. Other activities of the Company include manufacturing and trading beer, wine and soft drinks (excluding bar business). As of December 31, 2012, the Company had three subsidiaries operating in the similar industry. As of the same date, it had 14 branches.
Sector
Pharmaceuticals
Chiffre d''affaires - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -8.99% | 132M | |
| +51.63% | 796B | |
| +41.51% | 628B | |
| -5.10% | 358B | |
| +19.90% | 331B | |
| +9.95% | 301B | |
| +17.66% | 244B | |
| +3.39% | 228B | |
| +10.75% | 214B | |
| +6.99% | 165B |
- Stock Market
- Equities
- TRA Stock
